Skip to main content
. 2019 Jul 31;2(2):78–83. doi: 10.1016/j.jimed.2019.07.005

Fig. 1.

Fig. 1

Patients selection flow. HCC, hepatocellular carcinoma. HAIC, hepatic arterial infusion chemotherapy. OXA, oxaliplatin. SoraOXA group = sorafenib plus hepatic arterial infusion of oxaliplatin. Sorafenib group = Sorafenib monotherapy group.